Next Article in Journal
Chemically-Induced Production of Anti-Inflammatory Molecules in Microalgae
Next Article in Special Issue
Nile Tilapia Derived TP4 Shows Broad Cytotoxicity toward to Non-Small-Cell Lung Cancer Cells
Previous Article in Journal
Preparation of the Sodium Alginate-g-(Polyacrylic Acid-co-Allyltrimethylammonium Chloride) Polyampholytic Superabsorbent Polymer and Its Dye Adsorption Property
Previous Article in Special Issue
Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2018, 16(12), 477;

The Anti-Angiogenic Activity of a Cystatin F Homologue from the Buccal Glands of Lampetra morii

School of Life Sciences, Liaoning Normal University, Dalian 116081, China
These authors contributed equally.
Author to whom correspondence should be addressed.
Received: 12 November 2018 / Accepted: 27 November 2018 / Published: 29 November 2018
(This article belongs to the Collection Marine Compounds and Cancer)
Full-Text   |   PDF [6312 KB, uploaded 2 December 2018]   |  


Cystatins are a family of cysteine protease inhibitors which are associated with a variety of physiological and pathological processes in vivo. In the present study, the cDNA sequence of a cystatin F homologue called Lm-cystatin F was cloned from the buccal glands of Lampetra morii. Although Lm-cystatin F shares a lower homology with cystatin superfamily members, it is also composed of a signal peptide and three highly conserved motifs, including the G in the N-terminal, QXVXG, as well as the PW in the C-terminal of the sequence. After sequence optimization and recombination, the recombinant protein was expressed as a soluble protein in Escherichia coli with a molecular weight of 19.85 kDa. Through affinity chromatography and mass spectrometry analysis, the purified protein was identified as a recombinant Lm-cystatin F (rLm-cystatin F). Additionally, rLm-cystatin F could inhibit the activity of papain. Based on MTT assay, rLm-cystatin F inhibited the proliferation of human umbilical vein endothelial cells (HUVECs) dose dependently with an IC50 of 5 μM. In vitro studies show that rLm-cystatin F suppressed the adhesion, migration, invasion, and tube formation of HUVECs, suggesting that rLm-cystatin F possesses anti-angiogenic activity, which provides information on the feeding mechanisms of Lampetra morii and insights into the application of rLm-cystatin F as a potential drug in the future. View Full-Text
Keywords: Lampetra morii; buccal gland; cystatin F; anti-angiogenesis; cystatin superfamily Lampetra morii; buccal gland; cystatin F; anti-angiogenesis; cystatin superfamily

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

Printed Edition Available!
A printed edition of this Special Issue is available here.

Share & Cite This Article

MDPI and ACS Style

Zhu, M.; Li, B.; Wang, J.; Xiao, R. The Anti-Angiogenic Activity of a Cystatin F Homologue from the Buccal Glands of Lampetra morii. Mar. Drugs 2018, 16, 477.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top